Canada reaches vaccine agreement with companies

By: |
September 23, 2020 12:55 PM

On Tuesday, the companies reiterated their commitment to make the vaccine affordable and available globally.

Canada, GlaxoSmithKline, Sanofi, COVID-19 vaccine, UK governments, GSK vaccine,latest news on coronavirus pandemic''Both companies have significant R&D and manufacturing capability worldwide and are already working hard to scale up production,'' Roger Conner, president of GSK's vaccine unit, said in a statement. (Photo source: Reuters)

Pharmaceutical giants GlaxoSmithKline and Sanofi have agreed to provide Canada with up to 72 million doses of their potential COVID-19 vaccine as governments buy up supplies of unproven treatments in hopes of ensuring supplies of whatever works.

On Tuesday, the companies reiterated their commitment to make the vaccine affordable and available globally. ”Both companies have significant R&D and manufacturing capability worldwide and are already working hard to scale up production,” Roger Conner, president of GSK’s vaccine unit, said in a statement.

”This announcement from the Government of Canada supports our ongoing efforts.” The agreement with Canada follows earlier deals with the US, European Union and UK governments.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 vaccine ‘diplomacy’: India to expand cooperation with neighboring countries for Coronavirus vaccine development
2Vitamin D deficiency found in COVID-19 patients; all you need to know about it
3Covid-19 update: Active cases in India drop below 6 lakh for the first time in 85 days